## Abbreviations  
ACE  
Angiotensin-converting enzyme (EC 3.4.15.1)  
ApoE  
ndogenous apoprotein E  
BHA  
butylated hydroxyanisole  
BIOPEP-UWM  
database of bioactive peptide sequences [68]  
Boc  
tert-butyloxycarbonyl  
CHD  
coronary heart disease  
CVD
cardiovascular disease  
DPP4  
dipeptidyl peptidase IV (EC 3.4.14.5)  
DPPH  
2,2-diphenyl-1-picryl-hydrazyl)  
Fmoc  
fluorenylmethyloxycarbonyl  
GIP  
glucose-dependent insulinotropic polypeptide  
GLP-1  
glucagon-like peptide 1  
IP3
inositol 1,4,5-triphosphate  
LC-MS/MS  
Liquid Chromatography and Tandem Mass Spectrometry  
LDL cholesterol  
low density lipoprotein cholesterol  
MAPK  
mitogen-activated protein kinase  
MetS  
metabolic syndrome  
NHANES  
Health and Nutrition Examination Survey  
NO  
nitric oxide  
n neurotensin receptor 2  
ORAC-FL  
Oxygen Radical Absorbance Capacity with Fluorescein  
RAAS  
renin-angiotensin-aldosterone system  
RAS  
renin-angiotensin system  
ROS  
reactive oxygen species  
RR  
relative risk  
SBP  
systolic blood pressure  
SHR  
spontaneously hypertensive rats  
T2D  
type 2 diabetes mellitus  
t-BHQ  
tert-butyl hydroquinone  
VLDL cholesterol  
very low density lipoprotein cholesterol  
WSE  
water-soluble cheese extracts \begin{table}
\begin{tabular}{c c c c c} \hline
**BIOPEP-UWM ID** & **Activity** & **Sequence** & **Protein** & **Location** \\ \hline
3556 & 9 & FY & \(\alpha_{\text{G1}}\)-casein & (160–161), (168–169) \\ \cline{3-5}  & & & \(\alpha_{\text{G2}}\)-casein & (103–104) \\ \hline
7598/8524 & 1 & GA & \(\alpha_{\text{G1}}\)-casein & (177–178) \\ \cline{3-5}  & & & \(\kappa\)-casein & (20–21) \\ \hline
7615/8781 & 1 & GE & \(\beta\)-casein & (10–11) \\ \cline{3-5}  & & & \(\kappa\)-casein & (149–150) \\ \hline
7596/8785 & 1 & GI & \(\alpha_{\text{G1}}\)-casein & (141–142) \\ \hline
7611 & 9 & GK & \(\alpha_{\text{G1}}\)-casein & (48–49) \\ \hline
7599/8561 & 1 & GL & \(\alpha_{\text{G1}}\)-casein & (25–26) \\ \cline{3-5}  & & & \(\kappa\)-casein & (60–61) \\ \hline
3169/7512 & 1 & GP & \(\alpha_{\text{G2}}\)-casein & (117–118) \\ \cline{3-5}  & & & \(\beta\)-casein & (64–65), (199–200), (203–204) \\ \hline
7607 & 9 & GS & \(\alpha_{\text{G1}}\)-casein & (60–61), (202–203) \\ \cline{3-5}  & & & \(\alpha_{\text{G2}}\)-casein & (70–71) \\ \hline
7612 & 9 & GT & \(\alpha_{\text{G1}}\)-casein & (185–186) \\ \hline
7608/8786 & 1 & GV & \(\alpha_{\text{G1}}\)-casein & (152–153) \\ \cline{3-5}  & & & \(\beta\)-casein & (94–95) \\ \hline
3532/8788 & 1 & GY & \(\alpha_{\text{G1}}\)-casein & (108–109) \\ \hline
3184 & 12 & HA & \(\alpha_{\text{G1}}\)-casein & (143–144) \\ \hline
8793 & 12 & HI & \(\alpha_{\text{G1}}\)-casein & (95–96) \\ \hline
7844 & 9 & HK & \(\beta\)-casein & (106–107) \\ \hline
3317/7602/8557 & 7 & HL & \(\beta\)-casein & (134–135) \\ \cline{3-5}  & & & \(\kappa\)-casein & (123–124) \\ \hline
7842/8520 & 1 & HP & \(\alpha_{\text{G1}}\)-casein & (19–20) \\ \cline{3-5}  & & & \(\kappa\)-casein & (119–120), (121–122) \\ \cline{3-5}  & & & \(\beta\)-casein & (50–51) \\ \hline
8795 & 12 & HS & \(\alpha_{\text{G1}}\)-casein & (136–137) \\ \hline
8797 & 12 & HV & \(\alpha_{\text{G2}}\)-casein & (21–22) \\ \hline
3494/8799 & 1 & HY & \(\alpha_{\text{G2}}\)-casein & (92–93) \\ \hline
7562/8525 & 1 & IA & \(\kappa\)-casein & (43–44), (146–147) \\ \hline
7827 & 9 & IE & \(\beta\)-casein & (30–31) \\ \cline{3-5}  & & & \(\kappa\)-casein & (174–175) \\ \hline
7593 & 9 & IF & \(\alpha_{\text{G2}}\)-casein & (5–6) \\ \hline
7595 & 9 & IG & \(\alpha_{\text{G1}}\)-casein & (59-60), (151-152), (201-202) \\ \cline{3-5}  & & & \(\alpha_{\text{G2}}\)-casein & (69–70) \\ \hline
8800 & 12 & IH & \(\alpha_{\text{G1}}\)-casein & (142–143) \\ \cline{3-5}  & & & \(\beta\)-casein & (49–50) \\ \hline
8801 & 12 & II & \(\alpha_{\text{G2}}\)-casein & (29–30) \\ \cline{3-5}  & & & \(\beta\)-casein & (207–208) \\ \hline
8802/9079 & 1 & IL & \(\alpha_{\text{G1}}\)-casein & (5–6) \\ \cline{3-5}  & & & \(\kappa\)-casein & (11–12), (94–95) \\ \hline \end{tabular}
\end{table} 
Table 1: _Cont._